Cleo Diagnostics Ltd (COV) — Cash Flow-to-Debt Ratio
Cleo Diagnostics Ltd (COV) has a Cash Flow-to-Debt Ratio of -1.47x as of December 2025, meaning its operating cash flow of AU$-1.67 Million could theoretically repay -1% of its total liabilities (AU$1.14 Million) in one year. See COV current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cleo Diagnostics Ltd Cash Flow-to-Debt Ratio (2023–2025)
Historical debt coverage capacity for Cleo Diagnostics Ltd across 3 annual periods. Also explore how fast is Cleo Diagnostics Ltd growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Cleo Diagnostics Ltd (2023–2025)
Year-by-year debt coverage analysis for Cleo Diagnostics Ltd. For market capitalisation and broader financial context, see market cap of Cleo Diagnostics Ltd.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.63x | AU$-2.90 Million | AU$1.10 Million | ▲ +36.9% |
| 2024 | -4.18x | AU$-2.03 Million | AU$486.22K | ▼ -1132.3% |
| 2023 | -0.34x | AU$-684.47K | AU$2.02 Million | — |